
BrTxGNN - Drug Repurposing Explorer
藥提醒科技有限公司
BrTxGNN is a SMART on FHIR application that provides AI-predicted drug repurposing candidates for ANVISA-approved medications in Brazil. It leverages the TxGNN knowledge graph and deep learning models to predict new therapeutic indications for existing drugs.
Features:
- Automatically retrieves patient medications from EHR via FHIR
- Maps drugs using RxNorm and fuzzy matching to a database of 1,249 medications
- Displays repurposing predictions with 5,407 predicted indications
- Evidence levels (L1-L5) based on knowledge graph and deep learning validation
- Integrated ClinicalTrials.gov search for related clinical trials
- Localized Portuguese (pt-BR) interface
- Standalone mode available for testing without EHR connection
FHIR Endpoint: https://brtxgnn.yao.care/fhir
Standalone Demo: https://brtxgnn.yao.care/smart/standalone.html
This tool is for research purposes only and does not constitute medical advice.
Designed for
Application Type
FHIR Compatibility
Categories
Licensing & Pricing
Report Listing
